Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116739939> ?p ?o ?g. }
- W2116739939 endingPage "1812" @default.
- W2116739939 startingPage "1805" @default.
- W2116739939 abstract "The Lesch-Nyhan syndrome is characterized clinically by choreoathetosis, spasticity, selfmutilation, and mental and growth retardation. Biochemically, there is a striking reduction of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity in affected individuals. We have examined erythrocytes from 14 patients with the Lesch-Nyhan syndrome for the presence of hypoxanthine-guanine phosphoribosyltransferase activity and enzyme protein. In contrast to the usual finding of no detectable hypoxanthine-guanine phosphoribosyltransferase activity, we have found low levels (0.002-0.79 nmoles/mg protein per hr) of hypoxanthine-guanine phosphoribosyltransferase activity in erythrocyte lysates from five of these patients. In three of the five patients, hypoxanthine-guanine phosphoribosyltransferase activity appeared to be substantially more labile in vivo than normal using erythrocytes which had been separated according to their density (age). Immunochemical studies using a monospecific antiserum prepared from a homogeneous preparation of normal human erythrocyte hypoxanthine-guanine phosphoribosyltransferase revealed immunoreactive protein (CRM) in hemolysate from all 14 patients with the Lesch-Nyhan syndrome. The immunoreactive protein from each patient gave a reaction of complete identity with normal erythrocyte hypoxanthine-guanine phosphoribosyltransferase and was present in quantities equal to those observed in normal erythrocytes. In addition, a constant amount of CRM was found in erythrocytes of increasing density (age) from patients with the Lesch-Nyhan syndrome despite the decreasing hypoxanthine-guanine phosphoribosyltransferase activity. These studies confirm previous data which indicate that the mutations leading to the Lesch-Nyhan syndrome are usually, if not always on the structural gene coding for hypoxanthine-guanine phosphoribosyltransferase. In addition, although the mutant proteins appear to be present in normal amounts, they are often very labile in vivo with respect to enzymatic activity. These observations suggest that therapy directed at stabilization or activation of enzyme activity in vivo may be of potential benefit." @default.
- W2116739939 created "2016-06-24" @default.
- W2116739939 creator A5019328849 @default.
- W2116739939 creator A5053596029 @default.
- W2116739939 creator A5087378867 @default.
- W2116739939 date "1972-07-01" @default.
- W2116739939 modified "2023-10-12" @default.
- W2116739939 title "Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome" @default.
- W2116739939 cites W1523075306 @default.
- W2116739939 cites W1570900932 @default.
- W2116739939 cites W1775749144 @default.
- W2116739939 cites W1967811137 @default.
- W2116739939 cites W1968297117 @default.
- W2116739939 cites W1983094030 @default.
- W2116739939 cites W1998084168 @default.
- W2116739939 cites W2008903930 @default.
- W2116739939 cites W2009543343 @default.
- W2116739939 cites W2011027819 @default.
- W2116739939 cites W2018124448 @default.
- W2116739939 cites W2040474150 @default.
- W2116739939 cites W2050527189 @default.
- W2116739939 cites W2060582018 @default.
- W2116739939 cites W2062055152 @default.
- W2116739939 cites W2068768192 @default.
- W2116739939 cites W2073307065 @default.
- W2116739939 cites W2092342343 @default.
- W2116739939 cites W2120613619 @default.
- W2116739939 cites W2396876057 @default.
- W2116739939 cites W2398499051 @default.
- W2116739939 doi "https://doi.org/10.1172/jci106982" @default.
- W2116739939 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/292328" @default.
- W2116739939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4624352" @default.
- W2116739939 hasPublicationYear "1972" @default.
- W2116739939 type Work @default.
- W2116739939 sameAs 2116739939 @default.
- W2116739939 citedByCount "61" @default.
- W2116739939 countsByYear W21167399392012 @default.
- W2116739939 countsByYear W21167399392014 @default.
- W2116739939 crossrefType "journal-article" @default.
- W2116739939 hasAuthorship W2116739939A5019328849 @default.
- W2116739939 hasAuthorship W2116739939A5053596029 @default.
- W2116739939 hasAuthorship W2116739939A5087378867 @default.
- W2116739939 hasBestOaLocation W21167399391 @default.
- W2116739939 hasConcept C104317684 @default.
- W2116739939 hasConcept C126322002 @default.
- W2116739939 hasConcept C134018914 @default.
- W2116739939 hasConcept C143065580 @default.
- W2116739939 hasConcept C169760540 @default.
- W2116739939 hasConcept C181199279 @default.
- W2116739939 hasConcept C185592680 @default.
- W2116739939 hasConcept C2776476023 @default.
- W2116739939 hasConcept C2777766392 @default.
- W2116739939 hasConcept C2777991568 @default.
- W2116739939 hasConcept C2778301229 @default.
- W2116739939 hasConcept C2778559928 @default.
- W2116739939 hasConcept C2781116151 @default.
- W2116739939 hasConcept C2781196186 @default.
- W2116739939 hasConcept C2909697302 @default.
- W2116739939 hasConcept C40507961 @default.
- W2116739939 hasConcept C512185932 @default.
- W2116739939 hasConcept C55493867 @default.
- W2116739939 hasConcept C71924100 @default.
- W2116739939 hasConcept C78179603 @default.
- W2116739939 hasConcept C86803240 @default.
- W2116739939 hasConceptScore W2116739939C104317684 @default.
- W2116739939 hasConceptScore W2116739939C126322002 @default.
- W2116739939 hasConceptScore W2116739939C134018914 @default.
- W2116739939 hasConceptScore W2116739939C143065580 @default.
- W2116739939 hasConceptScore W2116739939C169760540 @default.
- W2116739939 hasConceptScore W2116739939C181199279 @default.
- W2116739939 hasConceptScore W2116739939C185592680 @default.
- W2116739939 hasConceptScore W2116739939C2776476023 @default.
- W2116739939 hasConceptScore W2116739939C2777766392 @default.
- W2116739939 hasConceptScore W2116739939C2777991568 @default.
- W2116739939 hasConceptScore W2116739939C2778301229 @default.
- W2116739939 hasConceptScore W2116739939C2778559928 @default.
- W2116739939 hasConceptScore W2116739939C2781116151 @default.
- W2116739939 hasConceptScore W2116739939C2781196186 @default.
- W2116739939 hasConceptScore W2116739939C2909697302 @default.
- W2116739939 hasConceptScore W2116739939C40507961 @default.
- W2116739939 hasConceptScore W2116739939C512185932 @default.
- W2116739939 hasConceptScore W2116739939C55493867 @default.
- W2116739939 hasConceptScore W2116739939C71924100 @default.
- W2116739939 hasConceptScore W2116739939C78179603 @default.
- W2116739939 hasConceptScore W2116739939C86803240 @default.
- W2116739939 hasIssue "7" @default.
- W2116739939 hasLocation W21167399391 @default.
- W2116739939 hasLocation W21167399392 @default.
- W2116739939 hasLocation W21167399393 @default.
- W2116739939 hasLocation W21167399394 @default.
- W2116739939 hasOpenAccess W2116739939 @default.
- W2116739939 hasPrimaryLocation W21167399391 @default.
- W2116739939 hasRelatedWork W1979028903 @default.
- W2116739939 hasRelatedWork W1997134989 @default.
- W2116739939 hasRelatedWork W2004405662 @default.
- W2116739939 hasRelatedWork W2007317812 @default.
- W2116739939 hasRelatedWork W2047567471 @default.
- W2116739939 hasRelatedWork W2050161941 @default.